-
Abhishek Sharma: Indian cricket's 'new-generation superstar'
-
In-form Fernandez sets up Tokyo final against Russia's Shnaider
-
Marquez stretches MotoGP championship lead after Martin pulls out
-
Scam centres relocated from Cambodia operate in Madagascar
-
In-form Fernandez reaches Tokyo final
-
Marc Marquez on front row at Malaysian MotoGP as Martin ruled out
-
James, Maxey fuel 76ers over Knicks in NBA Cup thriller
-
Injured Martin out of Malaysian MotoGP in big title blow
-
High-speed, high-risk Route du Rhum yacht race sets off Sunday
-
US, S.Korea, Japan vow 'complete' N.Korea denuclearization
-
Fears of violence as France braces for Halloween protests
-
Nations commit to get nature goals back on track
-
OKC's Holmgren to miss at least eight weeks as Thunder injury woes deepen
-
US oil companies aim to squeeze more out of refineries
-
'Not very smart' - Verstappen slams Red Bull stable-mate after clash
-
How to Repurpose Old Furniture into New Treasures
-
Leclerc quickest in Mexico GP practice
-
Trump admin approves potential Patriot missiles sale to Ukraine
-
Polish riot police deployed as deposed court chief sets off crisis
-
Sun Goddess wins at Breeders' Cup, O'Brien leads Baffert
-
Young Canadians focus on mental health at key climate trial
-
Nations agree push to get nature goals on track
-
'Breath of fresh air' truce brings hope to Ukraine's ravaged Kherson
-
Leclerc shows practice pace as Antonelli prowls in Mexico
-
British king reflects on colonial atrocities in Guyana
-
Trump, Milei under pressure to explain Bolsonaro flight from Brazil
-
Nations agree crucial texts in overtime at UN nature summit
-
Hakimi bags hat-trick as Paris Saint-Germain rip Le Havre to pieces
-
NBA Trail Blazers lose guard Morant for four weeks
-
Polish riot police deployed after court chief suspended
-
UN nature summit in extra time as nations grapple for deal
-
Emery's focus fully on Fulham despite Barcelona tie
-
Complaints upheld against Swiss TV commentary on Israeli bobsleigher
-
Reigning champs chase history in New York Marathon
-
Tielemans glad Man Utd sticking with Carrick
-
Monaco taken off global money-laundering 'grey list'
-
Scottish police probe Andrew, Epstein stay at royal castle: UK media
-
Canada, EU launch new alliance with deals on Ukraine, minerals, AI
-
Medvedev into Vienna semis and books ATP Finals place
-
Tears, fear, anger: relatives of Spain train crash dead await fate
-
UN nature talks in extra time as nations struggle to reach deal
-
Spurs get Maddison boost ahead of Palace clash
-
Meta settles, leaving Snap sole defendant in new social media trial
-
French authorities fear new street violence at Halloween protests
-
Chelsea manager Alonso dismisses talk of Estevao loan deal
-
Rickelton, Mulder centuries lift South Africa's chances in Test decider
-
Thousands of students, workers hold peaceful protests in Italy
-
Maresca adamant Donnarumma can be dropped but first name selected
-
Iraola glad to raise Liverpool fans' hopes but says hard work ahead
-
EU and Canada to 'withstand shocks together' with new alliance
Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch
SCOTTSDALE, AZ / ACCESS Newswire / April 23, 2026 / Sibannac, Inc. (OTCID:SNNC), a trailblazer in psychedelic tourism and plant-medicine experiences, welcomes President Trump's executive order accelerating federal research into ibogaine, MDMA, psilocybin and related compounds.
Industry analysts and wellness travel operators predict a rapid expansion of a new niche: psychedelic-assisted wellness tourism tailored to veterans, law enforcement officers and first responders suffering from depression and PTSD.
Key points
Market growth: Early market models from private sector analysts estimate the psychedelic-assisted wellness tourism market could reach $5-$15 billion annually by 2030, driven by faster clinical development, regulatory clarity, and growing clinical adoption for trauma-related conditions.
Target segment opportunity: Veterans, law enforcement and first responders - groups with higher-than-average PTSD and treatment-resistant depression rates - could represent 10-25% of that market, implying potential annual revenues of roughly $500 million to $3.75 billion by 2030 for services specifically designed for these populations.
Drivers: Federal research acceleration is expected to shorten timelines for approved therapeutic protocols and expand licensed clinic networks domestically and internationally.
"Federal commitment to rigorous research unlocks both clinical and commercial pathways," said David Mersky, CEO of Sibannac. "When evidence-based psychedelic therapies are integrated into wellness travel programs, we can scale compassionate, high-quality care for veterans and first responders - and responsibly grow a significant new segment of the wellness tourism economy."
About Sibannac
Sibannac, Inc. (OTCID:SNNC) is a forward-thinking lifestyle and wellness company curating psychedelic and plant-medicine tours and experiences both in the United States and abroad, to those seeking new treatment modalities for trauma-related conditions and general consciousness expansion.
For additional information and product updates, follow us and sign up for updates at:
Sibannic, Inc.
www.snncinc.com
x.com/sibannacinc
Media Contact: [email protected]
Cautionary Note Regarding Forward-Looking Statements.
This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Sibannac, Inc. (the "Company"), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
SOURCE: Sibannac, Inc.
View the original press release on ACCESS Newswire
P.Santos--AMWN